Aptorum Group Limited Accounts Payables 2011-2026 | APM

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Aptorum Group Limited

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	3.24 M	2.59 M	1.25 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.24 M	1.25 M	2.36 M

Quarterly Accounts Payables Aptorum Group Limited

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	4.17 M	-	3.54 M	-	3.24 M	-	2.5 M	-	2.59 M	-	-	-	1.25 M	-	-	-	653 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.17 M	653 K	2.56 M

Accounts Payables of other stocks in the Biotechnology industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Atara Biotherapeutics ATRA	4.37 M	$ 6.88	33.08 %	$ 51.5 M	USA
BridgeBio Pharma BBIO	36.2 M	$ 65.8	0.67 %	$ 12.6 B	USA
Acorda Therapeutics ACOR	13.4 M	-	-24.86 %	$ 820 K	USA
Biogen BIIB	432 M	$ 187.79	1.5 %	$ 27.5 B	USA
I-Mab IMAB	570 M	-	-	$ 866 M	China
Benitec Biopharma BNTC	201 K	$ 12.61	11.02 %	$ 519 M	USA
BioXcel Therapeutics BTAI	16 M	$ 1.76	18.92 %	$ 4.46 M	USA
Aeglea BioTherapeutics AGLE	677 K	-	-	$ 1.01 B	USA
BeyondSpring BYSI	295 K	$ 1.46	0.92 %	$ 58.9 M	USA
Annovis Bio ANVS	1.29 M	$ 2.57	3.63 %	$ 23.2 M	USA
Cabaletta Bio CABA	4.55 M	$ 3.29	3.63 %	$ 3.84 M	USA
Catalyst Biosciences CBIO	355 K	$ 12.08	0.04 %	$ 795 M	USA
C4 Therapeutics CCCC	858 K	$ 3.54	16.28 %	$ 293 M	USA
Alpine Immune Sciences ALPN	4.29 M	-	-	$ 2.17 B	USA
AlloVir ALVR	247 K	-	4.14 %	$ 49.1 M	USA
Codexis CDXS	2.84 M	$ 1.27	3.25 %	$ 93.2 M	USA
Cerus Corporation CERS	28 M	$ 1.95	0.78 %	$ 372 M	USA
Adverum Biotechnologies ADVM	1.61 M	-	-	$ 86.2 M	USA
Cullinan Management CGEM	1.68 M	$ 15.42	-2.03 %	$ 902 M	USA
Coherus BioSciences CHRS	35.2 M	$ 1.93	5.77 %	$ 182 M	USA
Acer Therapeutics ACER	3.81 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	3.46 M	-	1052.0 %	$ 415 M	USA
Celldex Therapeutics CLDX	1.18 M	$ 31.55	7.2 %	$ 2.1 B	USA
Cellectar Biosciences CLRB	1.44 M	$ 2.87	3.99 %	$ 7.49 M	USA
AgeX Therapeutics AGE	1.41 M	-	-10.17 %	$ 12.2 K	USA
Applied Genetic Technologies Corporation AGTC	2.91 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	9.03 M	-	-	$ 3.67 B	USA
Akouos AKUS	1.28 M	-	0.23 %	$ 488 M	USA
Acasti Pharma ACST	601 K	-	4.01 %	$ 150 M	Canada
Collegium Pharmaceutical COLL	10.7 M	$ 37.35	0.15 %	$ 1.18 B	USA
Ampio Pharmaceuticals AMPE	750 K	-	-11.43 %	$ 502 K	USA
Corcept Therapeutics Incorporated CORT	40.4 M	$ 33.98	0.32 %	$ 3.53 B	USA
Catalyst Pharmaceuticals CPRX	11.2 M	$ 24.73	2.02 %	$ 3.02 B	USA
Corbus Pharmaceuticals Holdings CRBP	3.18 M	$ 9.56	19.35 %	$ 41.4 M	USA
Applied Therapeutics APLT	1.74 M	-	-	$ 8.42 M	USA
Atea Pharmaceuticals AVIR	12.9 M	$ 6.14	4.16 %	$ 500 M	USA
Cardiff Oncology CRDF	8.09 M	$ 2.01	6.65 %	$ 134 M	USA